The importance of the ketamine in depressive disorders
Filip, M.; Jasionowska, J.; Gałecki, P.
Polski Merkuriusz Lekarski Organ Polskiego Towarzystwa Lekarskiego 45(267): 134-136
2018
ISSN/ISBN: 1426-9686 PMID: 30240385 Document Number: 696255
Depressive disorders are the most common disease entities in psychiatry. Slightly more than 50% of patients diagnosed with major depressive disorder (MDD) were treated using available antidepressants have shown the complete remission, and over 1/3 of patients have not responded to conventional treatment presenting treatment-resistant depression (TRD). Possible treatment of this type of disorder is pharmacotherapy, which in some cases turns out to be ineffective. Scientists studying this problem suggest using ketamine - a drug known for being used in anaesthesiology and intensive therapy.